CLOs on the Move

Regeneron

www.regeneron.com

 
Get in the Ideas Business. At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work together to discover, invent, and develop biopharmaceutical medicines, we`re creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health. So connect with us. Tell us about you. Learn more about our life-changing medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for more information on how to engage with Regeneron on social media. An important note about privacy: Regeneron is ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.regeneron.com
  • 777 Old Saw Mill River Road
    Tarrytown, NY USA 10591
  • Phone: 914.847.7000

Executives

Name Title Contact Details
Jason Portnoy
Vice President, Associate General Counsel Profile
Laura Sarkis
Sr Director Assistant General Counsel Profile
Arunabha Bhoumik
Vice President, Associate General Counsel | Head, General Litigation and Government Investigations Profile
Donna Gambaccini
Director, Corporate Counsel Profile
Alicia Alterbaum
Director, Corporate Counsel Profile

Similar Companies

ApoCell

ApoCell is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OncoImmune

Based in Rockville, Maryland, OncoImmune is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biopharmaceuticals for the treatment of cancer and autoimmune disease.

Lumos Diagnostics

Lumos Diagnostics delivers custom diagnostic solutions by combining deep market insight with existing platform technologies, assay development capability and regulated manufacturing experience.

Sienna Biopharmaceuticals

Sienna Biopharmaceuticals is focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes, and physicians’ practice of medicine.

Day One Biopharmaceuticals

Day One Biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine.